Methods and Systems for Predicting Patient Responsiveness to Subcutaneous Neuromodulation Therapy as a Treatment for Hypertension
AssigneeValencia Technologies Corporation
InventorDavid K. L. Peterson
Life of this patent
Estimating the term…
Loading patent…
AssigneeValencia Technologies Corporation
InventorDavid K. L. Peterson
Estimating the term…
An exemplary method includes determining a variability of a plurality of measurements of a cardiovascular parameter of a patient suffering from hypertension, the plurality of measurements recorded one at a time over a predetermined time period. The method further includes comparing the determined variability with a predetermined reference value. If the comparing indicates that the determined variability is less than the predetermined reference value, the method includes designating the patient to be within a first class of patients representative of patients that are likely to be responsive to subcutaneous neuromodulation therapy as a treatment for hypertension. If the comparing indicates that the determined variability is greater than the predetermined reference value, the method includes designating the patient to be within a second class of patients representative of patients that are likely to be unresponsive to subcutaneous neuromodulation therapy as a treatment for hypertension. Corresponding systems and methods are also described.
A method comprising:
A method comprising:
A system comprising:
Dependencies are inferred from the claim text.